Picture of Faeth Therapeutics, logo

FTH Faeth Therapeutics, News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Sensei Biotherapeutics Reports Second Quarter 2021 Results

Aug 4 (Reuters) - Sensei Biotherapeutics Inc  SNSE.O :
    * SENSEI BIOTHERAPEUTICS REPORTS SECOND QUARTER 2021 RESULTS
AND
HIGHLIGHTS RECENT IN VIVO DATA FROM SNS-VISTA PROGRAM
    * SENSEI BIOTHERAPEUTICS - PLANS TO SELECT A LEAD SNS-VISTA
CANDIDATE AND INITIATE IND-ENABLING STUDIES BY YEAR-END 2021
    * SENSEI BIOTHERAPEUTICS - SNS-401-NG ON TRACK TO START
IND-ENABLING STUDIES IN SECOND HALF OF 2022
    * SENSEI BIOTHERAPEUTICS - EXPECTS CURRENT CASH BALANCE TO
FUND
OPERATIONS AT LEAST INTO FIRST HALF OF 2024
    * SENSEI BIOTHERAPEUTICS - QTRLY NET LOSS PER SHARE $0.32

Source text for Eikon:  ID:nGNX4Qv4m4 
Further company coverage:  SNSE.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Faeth Therapeutics,

See all news